Federal Circuit hears CRISPR argument The Federal Circuit has heard oral arguments in the appeal of the PTAB’s February 2017 ruling that the claims of patents granted by USPTO to Broad Institute, MIT and Harvard concerning CRISPR editing in eukaryotic...
Please log in
to read the rest of this article.
New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It's free to join and the benefits start straight away.